Dr. Ceren Kimna is a Technology and Services Leader at Deep Piction, an AI-driven biotechnology company accelerating therapeutic development through deep learning and cellular analysis. She also serves as Nanotechnology Team Lead at Helmholtz Munich's Institute for Intelligent Biotechnologies.

Dr. Kimna earned her PhD from Technical University of Munich, focusing on DNA nanotechnology and controlled drug delivery systems. She previously completed her Master's in Chemical Engineering at Izmir Institute of Technology and Bachelor's at Ege University in Turkey.

Dr. Kimna has published groundbreaking research in Nature Biotechnology and Journal of Controlled Release, pioneering nanocarrier imaging at single-cell resolution. Her work on DNA-stabilized mucin nanoparticles and sequential drug release systems has advanced precision medicine.

At Deep Piction, Dr. Kimna contributes to developing the SCP-Nano pipeline, which uses deep learning to map nanocarrier biodistribution across whole organisms at single-cell resolution. Her research on lipid nanoparticles and drug delivery has been featured in leading scientific journals.

Dr. Kimna's innovations enable detection of nanocarriers at doses 1000x lower than conventional imaging techniques, advancing targeted drug delivery for cancer and disease treatment. Her DNA nanotechnology work has opened new pathways for patient-specific precision medicine.